Summary

Electrophysiology Ablation Catheters (Cardiovascular Devices) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

Electrophysiology Ablation is applicable for a wide variety of arrhythmias and has an extremely high success rate with low rates of complication and recurrence. Arrhythmia is a condition of the heart in which the heart is either beating too fast, too slow or with an irregular rhythm. Conventional RF ablation catheters are used with RF generator to supply remedial, heat-based energy at a targeted space of cardiac tissue. RF energy, released through the catheter, destroys tissues which are involved in onset and maintenance of most atrial tachyarrhythmias. One unit refers to one conventional RF ablation catheter.

A cryoablation catheter consists of a thin, long versatile tube that transports pressurized refrigerant (cold liquid) to a particular location within the heart to treat cardiac arrhythmias. Cooling of the catheter tip throughout RF ablation is achieved by current saline through or round the tip of ablation catheter where RF current is being delivered. The catheter is irrigated outwardly and cooler temperature is maintained. The catheter machine-controlled power management provides temperature monitoring and creates larger lesions with lesser power consumption. Laser ablation catheters utilize a direct laser to perform the ablation.

Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model

Currently marketed electrophysiology ablation catheters and evolving competitive landscape -
- Insightful review of the key industry trends.
- Annualized total electrophysiology ablation catheters market revenue by segment and market outlooks from 2015-2028.
- Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -
- Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
- SWOT analysis for Electrophysiology Ablation Catheters market.
- Competitive dynamics insights and trends provided for Electrophysiology Ablation Catheters market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country specific overview of the healthcare system.
- Country specific reimbursement policies.
- Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Biosense Webster Inc, Abbott Laboratories, Boston Scientific Corp, Medtronic plc, CardioFocus Inc, Biotronik AG, Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
- CMO executives who must have deep understanding of the electrophysiology ablation catheters marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to buy

The model will enable you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving electrophysiology ablation catheters market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the electrophysiology ablation catheters market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific electrophysiology ablation catheters market from 2015-2028.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Companies Mentioned
Biosense Webster Inc
Abbott Laboratories
Boston Scientific Corp
Medtronic plc
CardioFocus Inc
Biotronik AG